Search Results - Martin Citron
- Showing 1 - 20 results of 33
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
The Biological and Pathological Function of the Presenilin-1 ΔExon 9 Mutation Is Independent of Its Defect to Undergo Proteolytic Processing by Harald Steiner, Helmut Romig, Melissa G. Grim, Uwe Philipp, Brigitte Pesold, Martin Citron, Ralf Baumeister, Christian Haass
Published 1999Artigo -
8
-
9
-
10
Expression of Alzheimer’s Disease-associated Presenilin-1 Is Controlled by Proteolytic Degradation and Complex Formation by Harald Steiner, Anja Capell, Brigitte Pesold, Martin Citron, Peter M. Kloetzel, Dennis J. Selkoe, Helmut Romig, Klaus Mendla, Christian Haass
Published 1998Artigo -
11
-
12
The Proteolytic Fragments of the Alzheimer's Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex by Anja Capell, Jürgen Grünberg, Brigitte Pesold, Anke Diehlmann, Martin Citron, Ralph A. Nixon, Konrad Beyreuther, Dennis J. Selkoe, Christian Haass
Published 1998Artigo -
13
-
14
-
15
Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. by Martin Citron, Carmen Vigo‐Pelfrey, David B. Teplow, Christine Miller, D. Schenk, Jennifer Johnston, Bengt Winblad, Nikolaos Venizelos, Lars Lannfelt, D. J. Selkoe
Published 1994Artigo -
16
Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins by Weiming Xia, Jimin Zhang, Dora Kholodenko, Martin Citron, Marcia B. Podlisny, David B. Teplow, Christian Haass, Peter Seubert, Edward H. Koo, Dennis J. Selkoe
Published 1997Artigo -
17
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson’s disease by D. L. Price, Asma Khan, Rachel Angers, Á. de Pablo Cárdenas, Maria Key Prato, Massimo Bani, Douglas W. Bonhaus, Martin Citron, Anja‐Leona Biere
Published 2023Artigo -
18
Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an <i>in vivo</i> substrate for protein kinase C by Jochen Walter, Jürgen Grünberg, Anja Capell, Brigitte Pesold, Alice Schindzielorz, Martin Citron, Klaus Mendla, Peter St George–Hyslop, Gerd Multhaup, Dennis J. Selkoe, Christian Haass
Published 1997Artigo -
19
In Vivo Cleavage of α2,6-Sialyltransferase by Alzheimer β-Secretase by Shinobu Kitazume, Kazuhiro Nakagawa, Ritsuko Oka, Yuriko Tachida, Kazuko Ogawa, Yi Luo, Martin Citron, Hiroshi Shitara, Choji Taya, Hiromichi Yonekawa, James C. Paulson, Eiji Miyoshi, Naoyuki Taniguchi, Yasuhiro Hashimoto
Published 2004Artigo -
20
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models by Xiyun Chai, Su Wu, Tracey K. Murray, Robert D. Kinley, Claire V. Cella, Helen Sims, Nicola Buckner, Jenna Hanmer, Peter Davies, Michael J. O’Neill, Michael Hutton, Martin Citron
Published 2011Artigo
Search Tools:
Related Subjects
Biology
Disease
Medicine
Biochemistry
Alzheimer's disease
Chemistry
Internal medicine
Amyloid precursor protein
Cell biology
Gene
Pathology
Neuroscience
Enzyme
Amyloid precursor protein secretase
Amyloid (mycology)
Genetics
Amyloid beta
Immunology
Molecular biology
Presenilin
Computer science
P3 peptide
Protease
Alpha-synuclein
Antibody
BETA (programming language)
Biophysics
Cleavage (geology)
Fracture (geology)
Genetically modified mouse